“In silico studies on modified hydroxamic acid and valporic acid as potential inhibitors for HDAC2”, Bangladesh J Pharmacol, vol. 8, no. 3, pp. 328–335, Jul. 2013, doi: 10.3329/bjp.v8i3.15433.